Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3636)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 14, 2023 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Brzdęk M, Zarębska-Michaluk D, Invernizzi F, Cilla M, Dobrowolska K, Flisiak R. Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C. World J Gastroenterol 2023; 29(6): 949-966 [PMID: 36844142 DOI: 10.3748/wjg.v29.i6.949] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v29/i6/949.htm |
| Number | Citing Articles |
| 1 |
Muhammad Shahab, Abbas Khan, Salman Ali Khan, Guojun Zheng. Unraveling the mechanisms of Sofosbuvir resistance in HCV NS3/4A protease: Structural and molecular simulation-based insights. International Journal of Biological Macromolecules 2024; 267: 131629 doi: 10.1016/j.ijbiomac.2024.131629
|
| 2 |
Krystyna Dobrowolska, Michał Brzdęk, Piotr Rzymski, Robert Flisiak, Małgorzata Pawłowska, Jakub Janczura, Kinga Brzdęk, Dorota Zarębska-Michaluk. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals. Expert Opinion on Pharmacotherapy 2024; 25(7): 833 doi: 10.1080/14656566.2024.2358139
|
| 3 |
Michał BRZDĘK, Dorota ZARĘBSKA-MICHALUK, Krzysztof TOMASIEWICZ, Magdalena TUDRUJEK-ZDUNEK, Beata LORENC, Włodzimierz MAZUR, Hanna BERAK, Justyna JANOCHA-LITWIN, Jakub KLAPACZYŃSKI, Marek SITKO, Ewa JANCZEWSKA, Dorota DYBOWSKA, Anna PARFIENIUK-KOWERDA, Anna PIEKARSKA, Jerzy JAROSZEWICZ, Robert FLISIAK. Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people. Minerva Medica 2024; 115(3) doi: 10.23736/S0026-4806.24.09238-3
|
| 4 |
Abigail G. Ayers, Christia M. Victoriano, Samuel K. Sia. Integrated device for plasma separation and nucleic acid extraction from whole blood toward point-of-care detection of bloodborne pathogens. Lab on a Chip 2024; 24(22): 5124 doi: 10.1039/D4LC00571F
|
| 5 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
| 6 |
Ahmed B. Zaid, Shimaa K. Almady, Samah M. Awad, Mona G. Elabd, Sara A. Saied, AbdulRahman A Saied, Alshimaa M Elmalawany. Sofosbuvir (+) daclatasvir (+) ribavirin in Egyptian patients with hepatitis C virus: Therapeutic outcomes and the prognostic role of natural killer cells. Current Research in Translational Medicine 2024; 72(3): 103443 doi: 10.1016/j.retram.2024.103443
|
| 7 |
Jiyoung Lee, J.-H. James Ou. HCV-induced autophagy and innate immunity. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1305157
|
| 8 |
Agnieszka Genowska, Dorota Zarębska-Michaluk, Krystyna Dobrowolska, Krzysztof Kanecki, Paweł Goryński, Piotr Tyszko, Katarzyna Lewtak, Piotr Rzymski, Robert Flisiak. Trends in Hospitalizations of Patients with Hepatitis C Virus in Poland between 2012 and 2022. Journal of Clinical Medicine 2024; 13(18): 5618 doi: 10.3390/jcm13185618
|
| 9 |
Dorota Zarębska-Michaluk, Michał Brzdęk, Olga Tronina, Justyna Janocha-Litwin, Marek Sitko, Anna Piekarska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Barbara Sobala-Szczygieł, Magdalena Tudrujek-Zdunek, Łukasz Laurans, Robert Flisiak. Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination. BMC Medicine 2024; 22(1) doi: 10.1186/s12916-024-03699-z
|
| 10 |
Michał Brzdęk, Dorota Zarębska-Michaluk, Michał Kukla, Justyna Janocha-Litwin, Dorota Dybowska, Ewa Janczewska, Beata Lorenc, Hanna Berak, Włodzimierz Mazur, Magdalena Tudrujek-Zdunek, Jakub Klapaczyński, Anna Piekarska, Marek Sitko, Łukasz Laurans, Anna Parfieniuk-Kowerda, Robert Flisiak. Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices. Pharmacological Reports 2024; 76(5): 1114 doi: 10.1007/s43440-024-00639-9
|
| 11 |
Krystyna Dobrowolska, Małgorzata Pawłowska, Dorota Zarębska‐Michaluk, Piotr Rzymski, Ewa Janczewska, Magdalena Tudrujek‐Zdunek, Hanna Berak, Włodzimierz Mazur, Jakub Klapaczyński, Beata Lorenc, Justyna Janocha‐Litwin, Anna Parfieniuk‐Kowerda, Dorota Dybowska, Anna Piekarska, Rafał Krygier, Beata Dobracka, Jerzy Jaroszewicz, Robert Flisiak. Direct‐acting antivirals in women of reproductive age infected with hepatitis C virus. Journal of Viral Hepatitis 2024; 31(6): 309 doi: 10.1111/jvh.13936
|
| 12 |
Robert Flisiak, Dorota Zarębska‐Michaluk, Ewa Janczewska, Anna Parfieniuk‐Kowerda, Włodzimierz Mazur, Marek Sitko, Justyna Janocha‐Litwin, Rafał Krygier, Beata Lorenc, Anna Piekarska, Barbara Sobala‐Szczygieł, Krystyna Dobrowolska, Łukasz Socha, Jerzy Jaroszewicz. Sustained Virological Response After Early Discontinuation of Hepatitis C Treatment. Journal of Viral Hepatitis 2024; 31(11): 677 doi: 10.1111/jvh.13991
|
| 13 |
Piotr Rzymski, Michał Brzdęk, Krystyna Dobrowolska, Barbara Poniedziałek, Aleksandra Murawska-Ochab, Dorota Zarębska-Michaluk, Robert Flisiak. Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection. Viruses 2024; 16(9): 1386 doi: 10.3390/v16091386
|